Abstract
It has been suggested that genetic influences unmasked during neurodevelopment to produce schizophrenia may appear throughout neurodegeneration to produce AD plus psychosis. Risk of schizophrenia and psychosis in Alzheimer's disease (AD) has been linked to polymorphic variation at the dopamine receptor DRD3 gene implying similar causative mechanisms. We tested this association in a large cohort of Alzheimer's disease patients with a diagnosis of probable AD of 3 years or more duration from the relatively genetically homogenous Northern Irish population. We assessed relationships between genotypes/alleles of the DRD3 BalI polymorphism and the presence or absence of psychotic symptoms (delusions, hallucinations) in AD patients during the month prior to interview and at any stage during the dementia. No significant associations were found when delusions and hallucinations were cross-tabulated against S and G alleles and SS, SG and GG genotypes. Logistic regression failed to detect any influence of APOE, gender, family history or prior psychiatric history. In conclusion, we were unable to confirm previously reported associations between the DRD3 BalI polymorphism and psychotic symptoms in AD.
References
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Jul 1, 1984·Neurology·G McKhannE M Stadlan
Nov 22, 1996·American Journal of Medical Genetics·V L NimgaonkarA Chakravarti
Mar 1, 1997·Archives of General Psychiatry·D P DevanandY Stern
Feb 25, 1998·Journal of the American Geriatrics Society·D I KauferS T DeKosky
Jul 23, 1998·American Journal of Medical Genetics·C DubertretP Sokoloff
Aug 13, 1998·Human Molecular Genetics·C HolmesS Lovestone
Oct 21, 1998·Archives of Neurology·R A SweetS T DeKosky
Apr 22, 1999·The British Journal of Psychiatry : the Journal of Mental Science·T HopeR McShane
Mar 4, 2000·Journal of Medical Genetics·S P McIlroyA P Passmore
Sep 22, 2001·Biological Psychiatry·B NacmiasS Sorbi
Nov 28, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·C HolmesS Lovestone
Mar 29, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·V E GolimbetV I Trubnikov
Jul 10, 2002·Neurology·S A BacanuR A Sweet
Sep 27, 2002·International Journal of Geriatric Psychiatry·A EustaceB A Lawlor
Apr 17, 2003·British Journal of Cancer·UNKNOWN Scottish/Northern Irish BRCAI/BRCA2 Consortium
May 13, 2003·Molecular Psychiatry·R A SweetD V Jeste
Aug 21, 2003·The Journal of Neuropsychiatry and Clinical Neurosciences·Oscar L LopezSteven T DeKosky
Citations
Sep 1, 2005·Current Neurology and Neuroscience Reports·Dag AarslandClive Ballard
Jan 26, 2010·International Psychogeriatrics·Serge GauthierConstantine Lyketsos
Oct 3, 2006·Current Opinion in Psychiatry·Thomas W MeeksDilip V Jeste
Aug 13, 2008·Neuromolecular Medicine·Robyn CarsonA Peter Passmore
Aug 6, 2010·Expert Opinion on Drug Safety·Clive BallardDag Aarsland
Sep 6, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Constantine G LyketsosDavid S Miller
May 12, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·P HollingworthJ Williams
May 26, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Patricia A WilkoszRobert A Sweet
Feb 25, 2009·International Journal of Geriatric Psychiatry·Antonia L PritchardCorinne L Lendon
Jul 16, 2010·Expert Review of Molecular Diagnostics·Thomas ZetzscheHarald Hampel
Jan 13, 2016·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Chintan ShahRobert A Sweet
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mubashir HassanSung-Yum Seo